Literature DB >> 20470995

A review of endothelial dysfunction in diabetes: a focus on the contribution of a dysfunctional eNOS.

Chris R Triggle1, Hong Ding.   

Abstract

Although the etiology of vascular dysfunction in diabetes has been extensively investigated in both humans as well as animal models of human diabetes, the relative importance of the cellular pathways involved is still not fully understood. In this review, we focus on reviewing the literature that provides insights into how an acute exposure to hyperglycemia results in a dysregulation of endothelial nitric oxide synthase function, the subsequent downstream effects of endothelial nitric oxide synthase dysregulation, and the development of endothelial dysfunction. Copyright (c) 2010 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20470995     DOI: 10.1016/j.jash.2010.02.004

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  36 in total

1.  IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus.

Authors:  Joy Jones Buie; Ludivine L Renaud; Robin Muise-Helmericks; Jim C Oates
Journal:  J Immunol       Date:  2017-08-04       Impact factor: 5.422

2.  A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus.

Authors:  Maria Galán; Modar Kassan; Soo-Kyoung Choi; Megan Partyka; Mohamed Trebak; Daniel Henrion; Khalid Matrougui
Journal:  Hypertension       Date:  2012-06-04       Impact factor: 10.190

Review 3.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

4.  Pim1 kinase promotes angiogenesis through phosphorylation of endothelial nitric oxide synthase at Ser-633.

Authors:  Ming Chen; Bing Yi; Ni Zhu; Xin Wei; Guan-Xin Zhang; Shengdong Huang; Jianxin Sun
Journal:  Cardiovasc Res       Date:  2015-11-23       Impact factor: 10.787

5.  Augmented EGF receptor tyrosine kinase activity impairs vascular function by NADPH oxidase-dependent mechanism in type 2 diabetic mouse.

Authors:  Modar Kassan; Karima Ait-Aissa; Maha Ali; Mohamed Trebak; Khalid Matrougui
Journal:  Biochim Biophys Acta       Date:  2015-05-31

Review 6.  Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide.

Authors:  J David Symons; E Dale Abel
Journal:  Rev Endocr Metab Disord       Date:  2013-03       Impact factor: 6.514

7.  Spironolactone improves endothelial dysfunction in streptozotocin-induced diabetic rats.

Authors:  Heba Adel; Ashraf Taye; Mohamed M A Khalifa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-09-20       Impact factor: 3.000

Review 8.  Methylene blue for distributive shock: a potential new use of an old antidote.

Authors:  David H Jang; Lewis S Nelson; Robert S Hoffman
Journal:  J Med Toxicol       Date:  2013-09

Review 9.  Vascular considerations in glaucoma patients of African and European descent.

Authors:  Andrew Huck; Alon Harris; Brent Siesky; Nathaniel Kim; Michael Muchnik; Priyanka Kanakamedala; Annahita Amireskandari; Leslie Abrams-Tobe
Journal:  Acta Ophthalmol       Date:  2014-01-25       Impact factor: 3.761

10.  Nitrones reverse hyperglycemia-induced endothelial dysfunction in bovine aortic endothelial cells.

Authors:  Colwyn A Headley; David DiSilvestro; Kelsey E Bryant; Craig Hemann; Chun-An Chen; Amlan Das; Ouliana Ziouzenkova; Grégory Durand; Frederick A Villamena
Journal:  Biochem Pharmacol       Date:  2016-01-14       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.